VRTX
#113
Vertex Pharmaceuticals Incorporated - Common Stock
547.5 5 USD
0.00%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.05%
Monthly Change
+11.07%
6 month change
+10.48%
Year Change
+39.63%
Previous Close
547.2 9
Open
547.4 0
Low
547.4 0
High
547.5 5
Volume
229
Financials
- Market Capitalization 138.78 B
- Employee 6 400
- Founded 1989
- CEO Reshma Kewalramani
- Website www.vrtx.com
- Headquarter Massachusetts, United States
- FIGI BBG000C1S2X2
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
29.59
Price to sales ratio
9.75
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 205 |  REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 807.71 USD | -0.87% | -2.58% | +15.49% | +39.95% | 83.16 B USD | ||
| 259 |  ARGX argenx SE - American Depositary Shares | 1058.90 USD | +1.13% | +2.43% | +21.11% | +50.13% | 65.53 B USD | ||
| 290 |  MRNA Moderna, Inc. - Common Stock | 142.77 USD | -4.60% | +7.75% | +159.39% | +488.50% | 57.00 B USD | ||
| 339 |  RVMD Revolution Medicines, Inc. - Common Stock | 221.15 USD | +2.65% | +4.55% | +20.07% | +299.19% | 47.40 B USD |
Frequently asked questions about Vertex Pharmaceuticals Inc
What is the Vertex Pharmaceuticals Inc stock price today?
The current price of Vertex Pharmaceuticals Inc (VRTX) is 547.55. Over the past 24 hours, the stock has changed by +0.05%. Follow the VRTX chart for real-time price dynamics.
What is the stock ticker of Vertex Pharmaceuticals Inc?
Vertex Pharmaceuticals Inc trades under the ticker VRTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Vertex Pharmaceuticals Inc stock going up?
VRTX has changed by +0.45% over the last week, +11.07% over the last month, and +39.63% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Vertex Pharmaceuticals Inc?
Vertex Pharmaceuticals Inc currently has a market capitalization of 138.78 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Vertex Pharmaceuticals Inc earnings last quarter?
Last quarter, Vertex Pharmaceuticals Inc reported earnings of 4.34 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Vertex Pharmaceuticals Inc revenue for the last quarter?
Vertex Pharmaceuticals Inc reported quarterly revenue of 3.33 B. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Vertex Pharmaceuticals Inc net income for the last quarter?
Vertex Pharmaceuticals Inc reported net income of 1.1 B for the last quarter. The previous quarter showed 1.03 B, which means net income changed by +6.63%.
How many employees does Vertex Pharmaceuticals Inc have?
As of the latest available data, Vertex Pharmaceuticals Inc has 6 400 employees. Workforce size can provide additional context about the company's scale and operations.
What is Vertex Pharmaceuticals Inc EBITDA?
Vertex Pharmaceuticals Inc EBITDA is 1.3 B, and its EBITDA margin is 39.1%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Vertex Pharmaceuticals Inc stock?
You can buy Vertex Pharmaceuticals Inc (VRTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Vertex Pharmaceuticals Inc stock?
Investing in Vertex Pharmaceuticals Inc requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the VRTX chart and related analysis on metatrader.com as part of your research.